# BriaCell Therapeutics Corp.: Form DEF 14A, filed Feb 12, 2026

- Company: [BriaCell Therapeutics Corp.](/companies/bctx.md) (CIK 1610820)
- Form: DEF 14A
- Filed: 2026-02-12
- Accepted by EDGAR: Feb 12, 2026, 16:00 ET
- Period: 2026-02-12
- Accession: 0001493152-26-006390
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm

Filed Feb 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-006390. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.